BRPI0414365A - composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes - Google Patents
composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetesInfo
- Publication number
- BRPI0414365A BRPI0414365A BRPI0414365-5A BRPI0414365A BRPI0414365A BR PI0414365 A BRPI0414365 A BR PI0414365A BR PI0414365 A BRPI0414365 A BR PI0414365A BR PI0414365 A BRPI0414365 A BR PI0414365A
- Authority
- BR
- Brazil
- Prior art keywords
- diabetes
- diagnosing
- kits
- reagents
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01146—11-Beta-hydroxysteroid dehydrogenase (1.1.1.146)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
"COMPOSIçõES, REAGENTES E KITS PARA, E MéTODOS DE DIAGNOSTICAR, MONITORAR E TRATAR OBESIDADE E/OU DIABETES". A presente invenção refere-se a treze novas variantes de divisão alternativa dos genes relacionados com a obesidade e/ou diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/659,782 US7176292B2 (en) | 2003-09-11 | 2003-09-11 | Ghrelin variant protein |
PCT/US2004/029230 WO2005026392A2 (en) | 2003-09-11 | 2004-09-09 | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0414365A true BRPI0414365A (pt) | 2006-11-14 |
Family
ID=34273528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0414365-5A BRPI0414365A (pt) | 2003-09-11 | 2004-09-09 | composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes |
Country Status (15)
Country | Link |
---|---|
US (2) | US7176292B2 (pt) |
EP (1) | EP1664346B1 (pt) |
JP (2) | JP2007504825A (pt) |
KR (1) | KR101081040B1 (pt) |
CN (1) | CN101023184A (pt) |
AT (1) | ATE480641T1 (pt) |
AU (2) | AU2004273053B2 (pt) |
BR (1) | BRPI0414365A (pt) |
CA (1) | CA2538514C (pt) |
DE (1) | DE602004029061D1 (pt) |
HK (1) | HK1092841A1 (pt) |
IL (2) | IL174195A (pt) |
NZ (1) | NZ546488A (pt) |
RU (1) | RU2420583C2 (pt) |
WO (1) | WO2005026392A2 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512971B2 (en) * | 2002-12-10 | 2013-08-20 | Echelon Biosciences, Inc. | Compounds and methods of use thereof for assaying lysophospholipase D activity |
US20050208658A1 (en) * | 2003-11-21 | 2005-09-22 | The University Of Maryland | RNA interference mediated inhibition of 11beta hydroxysteriod dehydrogenase-1 (11beta HSD-1) gene expression |
WO2005113747A2 (de) | 2004-05-21 | 2005-12-01 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Multizelluläre gewebe- und organkultursysteme |
WO2005119525A1 (en) * | 2004-06-04 | 2005-12-15 | Pfizer Products Inc. | 11βHSD1 CRYSTAL STRUCTURES FOR STRUCTURE BASED DRUG DESIGN |
WO2007055996A2 (en) * | 2005-11-03 | 2007-05-18 | Liat Mintz | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
KR101201055B1 (ko) * | 2006-03-13 | 2012-11-15 | 리아트 민쯔 | 악액질 및/또는 식욕감퇴 및/또는 식욕감퇴-악액질 및/또는영양장애 및/또는 지방이영양증 및/또는 근육 쇠약 및/또는 식욕-자극의 치료를 위한 그렐린 스플라이스 변이체의 용도 |
US7763707B2 (en) * | 2006-03-13 | 2010-07-27 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation |
EP2021365B1 (en) * | 2006-03-28 | 2012-05-30 | Liat Mintz | A ghrelin splice variant for use in the prevention or treatment of high cholesterol levels |
US8420365B2 (en) * | 2007-10-08 | 2013-04-16 | Bristol-Myers Squibb Company | 11βhydroxysteroid dehydrogenase type 1 |
WO2009113880A1 (en) | 2008-03-12 | 2009-09-17 | Christopher Joseph Pemberton | Biomarkers |
ES2372337B1 (es) * | 2010-06-10 | 2013-01-18 | Servicio Andaluz De Salud | Variante de la ghrelina y sus usos. |
US9657062B2 (en) | 2012-02-03 | 2017-05-23 | Zealand Pharma A/S | Ghrelin analogues |
CN102721819B (zh) * | 2012-06-28 | 2014-08-13 | 广州瑞博奥生物科技有限公司 | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 |
CN108138239B (zh) * | 2015-07-24 | 2022-08-30 | 高丽大学校产学协力团 | 用于确定衰老、确定肥胖症和诊断癌症的生物标志物和使用其的诊断试剂盒 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291653B1 (en) * | 1997-03-24 | 2001-09-18 | Zymogenetics, Inc. | Antibodies to motilin homologs |
US20040023874A1 (en) * | 2002-03-15 | 2004-02-05 | Burgess Catherine E. | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
US6967237B2 (en) * | 2000-05-30 | 2005-11-22 | Merck & Co., Inc. | Ghrelin analogs |
ATE504001T1 (de) * | 2001-08-17 | 2011-04-15 | Fujirebio Kk | Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel |
CA2468619A1 (en) * | 2001-12-21 | 2003-07-10 | Maxygen Aps | Adiponectin fragments and conjugates |
EP2277910A1 (en) * | 2001-12-21 | 2011-01-26 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP1463752A4 (en) * | 2001-12-21 | 2005-07-13 | Human Genome Sciences Inc | ALBUMIN FUSION PROTEINS |
EP1474445A4 (en) * | 2002-01-18 | 2007-02-21 | Protemix Corp Ltd | ADIPONECTIN GLYCO-ISOFORMS, AND USES THEREOF |
WO2003063894A1 (fr) * | 2002-01-31 | 2003-08-07 | Japan Science And Technology Agency | Agents ameliorant la resistance a l'insuline |
KR101201055B1 (ko) * | 2006-03-13 | 2012-11-15 | 리아트 민쯔 | 악액질 및/또는 식욕감퇴 및/또는 식욕감퇴-악액질 및/또는영양장애 및/또는 지방이영양증 및/또는 근육 쇠약 및/또는 식욕-자극의 치료를 위한 그렐린 스플라이스 변이체의 용도 |
-
2003
- 2003-09-11 US US10/659,782 patent/US7176292B2/en not_active Expired - Lifetime
-
2004
- 2004-09-09 KR KR1020067004972A patent/KR101081040B1/ko active IP Right Grant
- 2004-09-09 BR BRPI0414365-5A patent/BRPI0414365A/pt not_active IP Right Cessation
- 2004-09-09 RU RU2006111720/10A patent/RU2420583C2/ru not_active IP Right Cessation
- 2004-09-09 AU AU2004273053A patent/AU2004273053B2/en not_active Ceased
- 2004-09-09 JP JP2006526255A patent/JP2007504825A/ja active Pending
- 2004-09-09 WO PCT/US2004/029230 patent/WO2005026392A2/en active Application Filing
- 2004-09-09 EP EP04783470A patent/EP1664346B1/en not_active Expired - Lifetime
- 2004-09-09 CN CNA2004800262032A patent/CN101023184A/zh active Pending
- 2004-09-09 AT AT04783470T patent/ATE480641T1/de not_active IP Right Cessation
- 2004-09-09 NZ NZ546488A patent/NZ546488A/en not_active IP Right Cessation
- 2004-09-09 DE DE602004029061T patent/DE602004029061D1/de not_active Expired - Lifetime
- 2004-09-09 CA CA2538514A patent/CA2538514C/en not_active Expired - Fee Related
-
2006
- 2006-03-09 IL IL174195A patent/IL174195A/en not_active IP Right Cessation
- 2006-10-13 US US11/580,472 patent/US8088730B2/en active Active
- 2006-12-07 HK HK06113457.3A patent/HK1092841A1/xx not_active IP Right Cessation
-
2009
- 2009-07-28 IL IL200120A patent/IL200120A0/en unknown
-
2010
- 2010-08-20 AU AU2010212460A patent/AU2010212460A1/en not_active Abandoned
- 2010-12-01 JP JP2010268513A patent/JP5314658B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1664346A2 (en) | 2006-06-07 |
US20050059015A1 (en) | 2005-03-17 |
CA2538514A1 (en) | 2005-03-24 |
AU2004273053B2 (en) | 2010-05-20 |
IL174195A0 (en) | 2006-08-01 |
CN101023184A (zh) | 2007-08-22 |
NZ546488A (en) | 2009-01-31 |
RU2420583C2 (ru) | 2011-06-10 |
US7176292B2 (en) | 2007-02-13 |
JP5314658B2 (ja) | 2013-10-16 |
IL174195A (en) | 2012-08-30 |
JP2007504825A (ja) | 2007-03-08 |
DE602004029061D1 (de) | 2010-10-21 |
EP1664346B1 (en) | 2010-09-08 |
WO2005026392A3 (en) | 2005-08-11 |
CA2538514C (en) | 2014-04-08 |
RU2006111720A (ru) | 2007-10-20 |
AU2004273053A1 (en) | 2005-03-24 |
AU2010212460A1 (en) | 2010-09-09 |
ATE480641T1 (de) | 2010-09-15 |
IL200120A0 (en) | 2011-08-01 |
HK1092841A1 (en) | 2007-02-16 |
US8088730B2 (en) | 2012-01-03 |
US20070086997A1 (en) | 2007-04-19 |
JP2011182776A (ja) | 2011-09-22 |
WO2005026392A2 (en) | 2005-03-24 |
KR20060083208A (ko) | 2006-07-20 |
KR101081040B1 (ko) | 2011-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL174195A0 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes | |
ATE424560T1 (de) | Marker für neuromyelitis optica | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
NO20063624L (no) | FC region varianter | |
WO2006066118A3 (en) | Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment | |
DK1316801T3 (da) | Sammensætninger og fremgangsmåder til detektion og behandling af sygdomme og tilstande, som er relateret til kemokinreceptorer | |
WO2006020269A3 (en) | Biomarkers of neurodegenerative disease | |
WO2004074455A3 (en) | Fc REGION VARIANTS | |
ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
TW200736611A (en) | Methods and compositions for diagnosing ankylosing spondylitis using biomarkers | |
WO2007047408A3 (en) | Promac signature application | |
NO20064715L (no) | Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C) | |
ATE504833T1 (de) | Verfahren zur bestimmung des phänotyps von zellen | |
WO2003038444A3 (en) | Biomarkers of liver function | |
NO20052553D0 (no) | Cobalaminanalyse. | |
WO2003087761A3 (en) | Molecular profiling of disease and therapeutic response using phospho-specific antibodies | |
WO2004070025A3 (en) | Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders | |
SG146459A1 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes | |
EA200600012A1 (ru) | Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку | |
WO2007055996A3 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance | |
WO2005039573A3 (en) | Biomarkers for the prediction of drug-induced diarrhoea | |
DK1819354T3 (da) | Fremgangsmåder og forbindelser til behandling af diabetes | |
NO20033401D0 (no) | Kjemiske forbindelser | |
WO2005019454A8 (en) | Novel rat calcium channel subunits and related probes, cell lines and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |